Nifty

:

25069.20

Sensex

:

81785.74

-44.80 (-0.18%)
-118.96 (-0.15%)

Login

Nifty
Sensex

:
:

25069.20
81785.74

-44.80 (-0.18%)
-118.96 (-0.15%)

Abbott India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

72/99

BSE: 500488 | NSE: ABBOTINDIA

Watchlist

NSE BSE

30910.00

15-Sep-2025

Open
High
Low
Previous Close

30900
31400
30810
30980.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

5878
182764870
37000
25325

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

65,714.85
45.25
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

64,086.93
1.54%
14.38

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.38
8.26
6.21

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.62
12.99
7.02

PAT CAGR (%)

10 Years
5 Years
3 Years

18.68
15.41
14.21

P:E (Median)

8 Years
5 Years
3 Years

48.49
49.31
48.59

P:BV (Average)

8 Years
5 Years
3 Years

15.13
15.23
15.81

EV:EBITDA (Average)

8 Years
5 Years
3 Years

30.43
33.19
32.98

Earnings Forecasts:

(Updated: 16-09-2025)

Description 2024 2025 2026 2027
Adj EPS 665.62 744.95 845.97 943.65
P/E Ratio 46.44 41.49 36.54 32.76
Revenue 6409.15 7026.16 7648.36 8210.8
EBITDA 1694.6 1919.96 2178.04 2445.5
Net Income 1414.44 1583.02 1797.74 2005.23
ROA 25.46 26.28 27.16 24.58
P/B Ratio 15.52 13.87 11.83 9.93
ROE 35.66 35.29 35.03 33.35
FCFF 1084.61 1410.79 1651.45 1794.87
FCFF Yield 1.67 2.17 2.54 2.76
Net Debt -1431.25 -1833.3 -2293.8 -2808
BVPS 1992.14 2229.1 2613.34 3112.41

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 1,738.35 1,557.61 11.60% 1,604.59 1,438.63 11.54% 1,614.28 1,437.14 12.33% 1,632.67 1,494.14 9.27%
Expenses 1,292.76 1,166.60 10.81% 1,176.05 1,109.10 6.04% 1,178.19 1,049.45 12.27% 1,193.71 1,113.26 7.23%
EBITDA 445.59 391.01 13.96% 428.54 329.53 30.05% 436.09 387.69 12.48% 438.96 380.88 15.25%
EBIDTM 25.63% 25.10% 26.71% 22.91% 27.01% 26.98% 26.89% 25.49%
Other Income 72.84 67.33 8.18% 76.02 81.15 -6.32% 71.75 55.61 29.02% 60.48 55.51 8.95%
Interest 5.82 2.75 111.64% 3.92 2.81 39.50% 2.26 3.17 -28.71% 2.50 3.13 -20.13%
Depreciation 19.48 18.37 6.04% 17.93 18.19 -1.43% 17.99 17.97 0.11% 17.51 17.84 -1.85%
PBT 493.13 437.22 12.79% 482.71 389.68 23.87% 487.59 422.16 15.50% 479.43 415.42 15.41%
Tax 127.27 109.21 16.54% 115.67 102.62 12.72% 126.81 111.18 14.06% 120.82 102.48 17.90%
PAT 365.86 328.01 11.54% 367.04 287.06 27.86% 360.78 310.98 16.01% 358.61 312.94 14.59%
PATM 21.05% 21.06% 22.87% 19.95% 22.35% 21.64% 21.96% 20.94%
EPS 172.58 154.72 11.54% 173.13 135.41 27.86% 170.18 146.69 16.01% 169.16 147.61 14.60%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 6,589.89 6,409.15 5,848.91 5,348.73 4,913.32 4,310.02 4,093.14 3,678.60 3,298.50 2,902.56 2,614.50 Net Sales Growth 11.17% 9.58% 9.35% 8.86% 14.00% 5.30% 11.27% 11.52% 13.64% 11.02% Cost Of Goods Sold 3,592.54 3,496.78 3,220.61 2,975.06 2,657.21 2,390.92 2,315.63 2,088.60 1,900.43 1,714.96 1,494.45 Gross Profit 2,997.35 2,912.37 2,628.30 2,373.67 2,256.11 1,919.10 1,777.51 1,590.01 1,398.07 1,187.60 1,120.05 GP Margin 45.48% 45.44% 44.94% 44.38% 45.92% 44.53% 43.43% 43.22% 42.39% 40.92% 42.84% Total Expenditure 4,840.71 4,717.02 4,395.86 4,143.24 3,831.74 3,391.13 3,336.96 3,074.56 2,775.10 2,507.75 2,250.77 Power & Fuel Cost - 15.43 16.63 17.15 14.98 12.74 13.73 12.61 10.26 7.74 6.98 % Of Sales - 0.24% 0.28% 0.32% 0.30% 0.30% 0.34% 0.34% 0.31% 0.27% 0.27% Employee Cost - 587.54 576.58 563.59 579.46 492.65 476.11 435.58 393.69 345.27 341.09 % Of Sales - 9.17% 9.86% 10.54% 11.79% 11.43% 11.63% 11.84% 11.94% 11.90% 13.05% Manufacturing Exp. - 100.58 86.07 40.71 20.63 16.51 18.33 14.42 11.52 13.14 11.94 % Of Sales - 1.57% 1.47% 0.76% 0.42% 0.38% 0.45% 0.39% 0.35% 0.45% 0.46% General & Admin Exp. - 252.78 233.47 258.70 229.35 200.23 209.71 267.14 239.06 205.33 191.08 % Of Sales - 3.94% 3.99% 4.84% 4.67% 4.65% 5.12% 7.26% 7.25% 7.07% 7.31% Selling & Distn. Exp. - 192.93 210.47 217.97 249.77 199.90 222.07 191.15 156.94 148.33 152.27 % Of Sales - 3.01% 3.60% 4.08% 5.08% 4.64% 5.43% 5.20% 4.76% 5.11% 5.82% Miscellaneous Exp. - 70.98 52.03 70.06 80.34 78.18 81.38 65.05 63.19 72.98 152.27 % Of Sales - 1.11% 0.89% 1.31% 1.64% 1.81% 1.99% 1.77% 1.92% 2.51% 2.03% EBITDA 1,749.18 1,692.13 1,453.05 1,205.49 1,081.58 918.89 756.18 604.04 523.40 394.81 363.73 EBITDA Margin 26.54% 26.40% 24.84% 22.54% 22.01% 21.32% 18.47% 16.42% 15.87% 13.60% 13.91% Other Income 281.09 278.05 248.32 154.29 83.35 83.47 114.66 113.98 118.09 60.15 51.24 Interest 14.50 11.43 12.45 15.99 19.10 18.28 8.53 2.25 3.82 2.04 2.52 Depreciation 72.91 71.80 71.17 69.97 66.10 58.13 59.61 16.92 16.19 16.43 14.44 PBT 1,942.86 1,886.95 1,617.75 1,273.82 1,079.73 925.95 802.70 698.85 621.48 436.49 398.01 Tax 490.57 472.51 416.53 324.41 281.03 235.26 209.77 248.52 220.26 159.84 142.76 Tax Rate 25.25% 25.04% 25.75% 25.47% 26.03% 25.41% 26.13% 35.56% 35.44% 36.62% 35.87% PAT 1,452.29 1,414.44 1,201.22 949.41 798.70 690.69 592.93 450.33 401.22 276.65 255.25 PAT before Minority Interest 1,452.29 1,414.44 1,201.22 949.41 798.70 690.69 592.93 450.33 401.22 276.65 255.25 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 22.04% 22.07% 20.54% 17.75% 16.26% 16.03% 14.49% 12.24% 12.16% 9.53% 9.76% PAT Growth 17.22% 17.75% 26.52% 18.87% 15.64% 16.49% 31.67% 12.24% 45.03% 8.38% EPS 685.04 667.19 566.61 447.83 376.75 325.80 279.68 212.42 189.25 130.50 120.40

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 4,233.15 3,698.89 3,188.54 2,819.79 2,602.16 2,431.70 2,008.59 1,692.76 1,386.94 1,195.60 Share Capital 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 Total Reserves 4,183.02 3,637.48 3,124.77 2,754.38 2,536.64 2,374.69 1,959.59 1,650.56 1,352.37 1,174.35 Non-Current Liabilities 262.01 136.03 144.02 184.18 189.62 209.60 62.36 40.75 34.84 29.25 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 119.22 115.12 93.46 92.40 89.75 84.84 75.43 55.35 47.22 38.64 Current Liabilities 1,407.19 1,342.72 1,206.02 1,203.19 1,030.86 891.11 856.89 668.08 631.64 382.27 Trade Payables 1,057.86 1,002.69 891.99 889.45 762.67 657.77 663.52 480.62 474.69 230.14 Other Current Liabilities 161.67 159.58 177.30 174.02 136.76 118.25 89.42 81.80 77.90 86.90 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 187.66 180.45 136.73 139.72 131.43 115.09 103.96 105.66 79.05 65.23 Total Liabilities 5,902.35 5,177.64 4,538.58 4,207.16 3,822.64 3,532.41 2,927.84 2,401.59 2,053.42 1,607.12 Net Block 335.98 224.94 236.91 271.00 250.78 269.83 104.96 81.38 109.60 108.46 Gross Block 596.25 424.50 366.93 425.90 340.62 344.84 164.52 124.25 139.69 122.83 Accumulated Depreciation 260.27 199.56 130.02 154.90 89.84 75.01 59.56 42.87 30.10 14.37 Non Current Assets 1,137.24 1,931.80 1,513.47 354.12 335.23 327.76 166.85 136.12 160.41 156.49 Capital Work in Progress 18.08 10.11 3.66 0.66 0.66 1.64 0.73 2.17 6.28 2.83 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 74.90 80.18 97.88 79.35 78.80 50.91 56.69 48.91 41.53 42.47 Other Non Current Assets 708.28 1,616.57 1,175.02 3.11 4.99 5.38 4.47 3.66 3.00 2.73 Current Assets 4,741.59 3,245.84 3,025.11 3,853.04 3,487.41 3,204.65 2,760.98 2,265.47 1,893.02 1,450.63 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 882.04 619.58 648.85 687.82 717.59 527.17 606.79 585.33 500.63 370.10 Sundry Debtors 380.23 319.11 318.80 288.16 250.21 317.91 276.11 263.44 176.22 145.02 Cash & Bank 1,627.92 2,134.49 1,937.06 2,749.22 2,409.04 2,197.38 1,684.28 1,031.35 1,090.92 839.42 Other Current Assets 1,851.40 87.12 70.06 73.19 110.57 162.19 193.80 385.35 125.24 96.08 Short Term Loans & Adv. 1,569.20 85.54 50.34 54.65 42.78 105.79 93.24 289.55 106.23 79.51 Net Current Assets 3,334.40 1,903.12 1,819.09 2,649.85 2,456.55 2,313.54 1,904.09 1,597.39 1,261.38 1,068.36 Total Assets 5,878.83 5,177.64 4,538.58 4,207.16 3,822.64 3,532.41 2,927.83 2,401.59 2,053.43 1,607.12

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,011.84 1,212.81 893.39 947.66 726.74 626.13 499.13 152.70 307.22 248.68 PBT 1,886.95 1,617.75 1,273.82 1,079.73 925.95 802.70 698.85 621.48 436.49 398.01 Adjustment -164.63 -129.85 -62.70 23.30 24.99 -17.22 -77.46 -76.92 -37.02 -23.98 Changes in Working Capital -263.42 129.38 23.13 133.62 11.26 69.82 134.41 -186.96 66.52 21.85 Cash after chg. in Working capital 1,458.90 1,617.28 1,234.25 1,236.65 962.20 855.30 755.80 357.61 466.00 395.87 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -447.06 -404.47 -340.86 -288.99 -235.46 -229.17 -256.67 -204.90 -158.78 -147.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 182.18 -416.03 -147.71 -395.84 -71.82 -401.21 -257.00 -214.84 -155.41 -77.19 Net Fixed Assets -179.72 -64.02 55.97 -85.28 5.20 -181.23 -38.83 19.55 -20.31 93.90 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 361.90 -352.01 -203.68 -310.56 -77.02 -219.98 -218.17 -234.39 -135.10 -171.09 Cash from Financing Activity -925.17 -744.71 -638.72 -637.38 -581.79 -216.79 -142.80 -102.43 -89.76 -80.29 Net Cash Inflow / Outflow 268.85 52.07 106.96 -85.56 73.13 8.13 99.33 -164.56 62.05 91.19 Opening Cash & Equivalents 291.74 239.67 132.71 218.27 145.14 137.01 37.68 202.24 140.19 49.00 Closing Cash & Equivalent 560.59 291.74 239.67 132.71 218.27 145.14 137.01 37.68 202.24 140.19

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 1978.48 1721.76 1480.48 1306.18 1203.71 1127.50 932.19 786.76 646.43 562.65 ROA 25.53% 24.73% 21.71% 19.89% 18.78% 18.36% 16.90% 18.01% 15.12% 13.39% ROE 35.98% 35.31% 32.07% 29.95% 27.89% 27.09% 24.66% 26.35% 21.54% 23.93% ROCE 47.87% 47.34% 42.93% 40.53% 37.52% 36.54% 37.88% 40.61% 33.96% 37.55% Fixed Asset Turnover 12.93 15.27 13.85 13.12 13.04 16.07 25.48 25.06 22.39 15.63 Receivable days 19.34 19.26 20.18 19.54 23.19 26.49 26.77 24.26 19.95 18.91 Inventory Days 41.52 38.30 44.44 51.02 50.82 50.56 59.14 59.93 54.07 52.03 Payable days 107.54 107.36 109.28 113.47 108.42 78.62 76.56 66.93 54.71 38.57 Cash Conversion Cycle -46.68 -49.80 -44.66 -42.91 -34.41 -1.57 9.35 17.26 19.31 32.37 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 166.09 130.94 80.66 57.53 51.65 95.10 311.82 163.60 215.33 158.63

Top Investors:

sbi large & midcap fund

canara robeco mutual fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Abbott India - Quarterly Results
12th Aug 2025, 13:16 PM

Read More
Abbott, MSD Pharmaceuticals enter into partnership
19th Jun 2025, 14:12 PM

The companies have entered into partnership for distribution of oral anti-diabetic medicines in India
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback